Skip to main content

Market Overview

This Is What Whales Are Betting On Baxter Intl

Share:

Financial giants have made a conspicuous bullish move on Baxter Intl. Our analysis of options history for Baxter Intl (NYSE:BAX) revealed 17 unusual trades.

Delving into the details, we found 52% of traders were bullish, while 35% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $245,900, and 11 were calls, valued at $489,890.

Expected Price Movements

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $20.0 to $30.0 for Baxter Intl over the recent three months.

Volume & Open Interest Development

Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Baxter Intl's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Baxter Intl's significant trades, within a strike price range of $20.0 to $30.0, over the past month.

Baxter Intl Call and Put Volume: 30-Day Overview

Options Call Chart

Largest Options Trades Observed:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
BAX CALL TRADE BEARISH 01/15/27 $7.9 $4.5 $5.6 $20.00 $84.0K 283 155
BAX PUT TRADE BEARISH 09/19/25 $4.5 $4.3 $4.45 $27.50 $68.9K 3.1K 164
BAX CALL TRADE BEARISH 01/15/27 $7.7 $5.1 $5.75 $20.00 $57.5K 283 795
BAX PUT SWEEP BULLISH 11/21/25 $7.6 $5.7 $5.7 $30.00 $57.0K 303 0
BAX CALL SWEEP BULLISH 01/15/27 $5.2 $4.6 $5.1 $20.00 $50.6K 283 496

About Baxter Intl

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Following our analysis of the options activities associated with Baxter Intl, we pivot to a closer look at the company's own performance.

Where Is Baxter Intl Standing Right Now?

  • With a volume of 21,544,450, the price of BAX is down -18.93% at $22.74.
  • RSI indicators hint that the underlying stock may be oversold.
  • Next earnings are expected to be released in 0 days.

Expert Opinions on Baxter Intl

3 market experts have recently issued ratings for this stock, with a consensus target price of $33.67.

Unusual Options Activity Detected: Smart Money on the Move

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
* Maintaining their stance, an analyst from Morgan Stanley continues to hold a Underweight rating for Baxter Intl, targeting a price of $27.
* An analyst from Citigroup has decided to maintain their Neutral rating on Baxter Intl, which currently sits at a price target of $32.
* Consistent in their evaluation, an analyst from Evercore ISI Group keeps a Outperform rating on Baxter Intl with a target price of $42.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Baxter Intl options trades with real-time alerts from Benzinga Pro.

 

Related Articles (BAX)

View Comments and Join the Discussion!

Posted-In: BZI-UOAOptions Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com